top of page
Contact Us
Contact Us

More case studies

Ensuring batch-consistent, compliant comparator supply across NA, EU, and APAC - on time and uninterrupted.

Effective Sourcing of Semaglutide for a Global Phase III Clinical Trial

From supply shortfall to on-time first-patient-first-visit across Europe, delivered in three days.

CSI's 72-hour Abraxane Rescue Mission

Adaptive, multi-product supply across 22 countries and 80 sites, kept on time, in budget and compliant.

CSI’s Expert Delivery of a Global Respiratory Study

A leading global biopharmaceutical company urgently requested CSI to supply the Fluarix QIV Southern Hemisphere Vaccine for 2025.

Rapid Sourcing of Discontinued Southern Hemisphere Vaccine for a Global Biopharmaceutical Client

Securing reliable, cost-effective, long-term supply of Eylea PFS from EU and USA for a global biotech company’s clinical studies.

Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies

A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial.

Comparator Sourcing for a Phase II Ophthalmology Study

CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries

How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time

Export of expensive comparators from Europe to China with first leg documents and streamlined approach

CSI’s seamless comparator export to China

How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market

Rescuing a Global Biotech's Oncology Study with Cetuximab

How CSI fulfilled what our competitors couldn’t: rapidly sourcing oncology medication from the EU for a trial in South Korea

Rescuing a Biotech’s Oncology Trial with Lenvima

How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price

Delivering €1 million Savings for Pembrolizumab

How CSI supplied large quantities of Jakavi to a Biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67 site shipments

Global Jakavi Study

Challenge

CSI was tasked with providing crucial support to a large CRO company in distributing devices for a five-year and a three-year study spanning 18 countries in Europe (EU), South Africa, the United States (US) and Asia-Pacific (APAC). A central sourcing approach was not suitable for the client due to import and export complications, as well as the high VAT of the required product.


It was a particular challenge to find 18 warehouses that were able to accommodate the storage of the required devices within a short timeframe since they contained lithium batteries, which are classed as dangerous goods. The majority of GMP warehouses are limited to the storage of medication, which made qualification all the more complex.

Solution

After conducting a rigorous search and leveraging our networks, CSI identified suitable partner warehouses, auditing and qualifying them within the rapid timeframe required for the client’s study to progress without delay.

Result

With CSI’s outstanding supply chain solutions and expertise in import and export, we managed the delivery of stock to all depots and sites across the world. We also managed the returns and destructions of all devices.


CSI’s flexible approach to ancillary sourcing ensured we were able to supply all sites before the Site Initiation Visit (SIV), enabling the client’s study to commence on time.

Case Study

Global Device Distribution

CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay

Challenge

To distribute devices containing lithium batteries for a large CRO's five-year and three-year studies, spanning 18 countries around the world

Solution

CSI audited and qualified 14 new warehouses able to accommodate the devices (classed as dangerous goods) within a tight timeframe

Result

Stock was provided to all sites globally, the client’s study commenced without delay, and CSI managed all returns and destructions

Contact us 

Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements

bottom of page